LEXINGTON, KY – September 22, 2026 – Lexington Clinic Urology is now offering the Optilume® benign prostatic hyperplasia (BPH) procedure, bringing an innovative, minimally invasive treatment option to men experiencing symptoms associated with BPH, commonly known as enlarged prostate.
The Optilume BPH Catheter System combines mechanical dilation with coated balloon technology designed to improve urinary flow while helping maintain long-term treatment effectiveness.
BPH affects millions of men and becomes increasingly common with age. Symptoms may include frequent urination, difficulty starting or maintaining urinary flow, nighttime urination, and a sensation of incomplete bladder emptying.
Unlike more invasive surgical approaches, the outpatient Optilume procedure does not require permanent device implantation, and clinical studies have demonstrated significant improvements in urinary symptoms and flow rates while preserving function.
Patients now have access to a full spectrum of medical and surgical BPH therapies, including Optilume, HoLEP, Aquablation®, UroLift®, and TURP. This breadth of treatment options allows Lexington Clinic’s urologists to tailor care plans to each patient’s unique needs, symptoms, and goals.
About Lexington Clinic
Lexington Clinic is Central Kentucky’s oldest and largest independent multi-specialty group practice. Founded in 1920, the organization’s 200+ physicians provide healthcare across more than 40 specialties serving patients at more than 30 locations.
